Geron Corporation (GERN) News
Filter GERN News Items
GERN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GERN News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest GERN News From Around the Web
Below are the latest news stories about GERON CORP that investors may wish to consider to help them evaluate GERN as an investment opportunity.
Geron Stock Rallies More Than 60% in a Year: Here's WhyFDA's approval of GERN's Rytelo (imetelstat) for treating low- to intermediate-1 risk MDS drives the stock 61.1% higher in the past year. |
Here’s Why Geron Corp. (NASDAQ:GERN) Crashed TodayWe recently compiled a list of the 10 Firms Mirror Dow Jones Decline on Monday. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against the other stocks. Ten companies kicked off this week’s trading mirroring a decline on Dow Jones with a series of catalysts dampening investor sentiment. […] |
Why Is Geron Corporation (GERN) the Best Long-Term Penny Stock to Buy According to Hedge Funds?We recently published a list of the 12 Best Long-Term Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against the other best long-term penny stocks to buy. What’s the Future Like for Small Cap Stocks in 2025? On December […] |
Why GERN Stock (GERN) is SkyrocketingWe recently published a list of 10 Firms End 2024 Stronger With Impressive Gains. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the last day of the year, with Wall Street’s main indices […] |
Is Geron Corporation (GERN) the Best Penny Stock to Buy for 2025?We recently compiled a list of the 10 Best Penny Stocks to Buy for 2025. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against the other penny stocks. The US stock market has been on a roll owing to a powerful rally in the technology sector. The S&P […] |
High Growth Tech Stocks to Watch in December 2024Over the last 7 days, the United States market has dropped 1.1%, yet it remains up by an impressive 22% over the past year, with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and scalability potential to thrive amidst these market conditions. |
Why Is Geron Corporation (GERN) Among the Best Biotech Penny Stocks to Invest in Now?We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against the other best biotech penny stocks to invest in now. Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower […] |
Geron Corp. (GERN) Ends Trading Week Defying Market BloodbathWe recently compiled a list of the 10 Firms End Trading Week Defying Market Bloodbath. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against the other stocks. A wave of selling gripped Wall Street this Friday, pushing major indices lower as investors shifted capital towards more attractive investment […] |
Is Geron Corp. (GERN) the Biggest Loser of This Week?We recently compiled a list of the 10 Biggest Losers of This Week. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against the other stocks. Wall Street’s main indices all finished in the green during a shortened trading session this week, yet 10 companies–mainly technology stocks– still booked […] |
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)FOSTER CITY, Calif., December 19, 2024--Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 72,000 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company. |